Retrospective review of 492 patient from a small community hospital who did not qualify for participation in the Connect HF study sponsored by DCRI.
Retrospective review of adults above the age of 18 with a primary diagnosis of HFpEF between August 2017 and March 2018. Subjects had to fall into one of two classifications (NYHA Class II-IV or ACC/AHA Stage B-D) and had a life expectancy greater than 6 months are included. Individuals with a terminal illness other than HF, prior heart transplant or on a transplant list, or current/ planned left ventricular assist device excluded. The primary objective of this study is to identify risk factors for readmission in patients discharged with a diagnosis of HFpEF.
Study Type
OBSERVATIONAL
Enrollment
492
Retrospective review of study patients excluded from the CONNECT- HF trial who were discharged with a diagnosis of HFpEF between August 1, 2017 and March 1, 2018. Readmission rate at 30 and 90 days along with patient demographics and associated comorbidities were analyzed.
Ascension Macomb-Oakland Hospital
Warren, Michigan, United States
Readmission Risk Factors and Heart Failure with Preserved Ejection Fraction
Retrospective review to identify risk factors for readmission in patients discharged with a diagnosis of HFpEF.
Time frame: August 1, 2017 though March 1, 2018
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.